Dynamic monitoring of PD-L1 and Ki67 in circulating tumor cells of metastatic non-small cell lung cancer patients treated with pembrolizumab.

Mol Oncol · 2023 · PMC10158784 · PMID 36177552

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In the current investigation, we found that patients with reduced number of PD‐L1‐positive CTCs after first cycle showed a trend for longer PFS, but most importantly patients with decreased PD‐L1low CTC counts had a significantly longer PFS.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.